Get my own profile
Public access
View all52 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Xiaole Shirley LiuCEO, GV20 TherapeuticsVerified email at ds.dfci.harvard.edu
- Jun S LiuProfessor of statistics, Harvard UniversityVerified email at stat.harvard.edu
- Taiwen LiAssociate Professor, West China Hospital of Stomatology, Sichuan UniversityVerified email at scu.edu.cn
- Jingxin FuResearch Scientist, Medical Oncology Department, Dana-Farber Cancer InstituteVerified email at ds.dfci.harvard.edu
- Peng JiangStadtman Tenure-Track Investigator, National Cancer Institute, NIHVerified email at nih.gov
- Xihao HuGV20 TherapeuticsVerified email at gv20therapeutics.com
- Myles BrownEmil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolVerified email at dfci.harvard.edu
- Shengqing (Stan) GuThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
- Avinash SahuUniversity of New Mexico Cancer Center & TumorAI.orgVerified email at salud.unm.edu
- Jun LiCaltech, Stanford (previously), Michigan (current)Verified email at med.umich.edu
- Deng Pan, Ph.D.Assistant Professor, Tsinghua UniversityVerified email at tsinghua.edu.cn
- Sabina SignorettiProfessor, Brigham and Women's Hospital, Harvard Medical SchoolVerified email at bwh.harvard.edu
- Jean-Christophe PignonPrincipal ScientistVerified email at jouncetx.com
- Scott RodigProfessor of Pathology, Brigham & Women's HospitalVerified email at bwh.harvard.edu
- Hui ShenVan Andel Research InstituteVerified email at vai.org
- Vincent B. YoungUniversity of MichiganVerified email at umich.edu
- Casey TheriotNC State UniversityVerified email at ncsu.edu
- Chongzhi ZangAssociate Professor, University of VirginiaVerified email at virginia.edu
- Cliff MeyerDana-Farber Cancer Institute and Harvard T.H. Chan School of Public HealthVerified email at jimmy.harvard.edu
- Ruoxu DouDana-Farber Cancer InstituteVerified email at dfci.harvard.edu